title: Experimental model of chronic renal allograft rejection in rats and therapeutic efficacy of a new selective thromboxane A2 (TXA2) synthetase inhibitor (CV-4151).
authors.affiliation: Department of Urology and Surgery, Kidney Center, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Tanabe
authors.forename: H
authors.initials: H
authors.lastname: Toma
authors.forename: R
authors.initials: R
authors.lastname: Sagara
authors.forename: K
authors.initials: K
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Teraoka
authors.forename: K
authors.initials: K
authors.lastname: Ota
mesh_terms: D000818:Animals; D001794:Blood Pressure; D002908:Chronic Disease; D004195:Disease Models, Animal; D005229:Fatty Acids, Monounsaturated / Q000627:therapeutic use*; D006084:Graft Rejection; D007668:Kidney / Q000503:physiopathology; D016030:Kidney Transplantation; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D012016:Reference Values; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
chemical_list: D005229:Fatty Acids, Monounsaturated; D011725:Pyridines; D013930:Thromboxane-A Synthase; C045446:isbogrel